585 related articles for article (PubMed ID: 28386945)
1. Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy.
Lipton RB; Schmidt P; Diener HC
Headache; 2017 May; 57(5):756-765. PubMed ID: 28386945
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
Tepper SJ; Dodick DW; Schmidt PC; Kellerman DJ
Headache; 2019 Apr; 59(4):509-517. PubMed ID: 30698272
[TBL] [Abstract][Full Text] [Related]
3. IM ketorolac vs diclofenac potassium powder for oral solution for the acute treatment of severe migraine: a randomized controlled trial.
Engel ER; Cheng J
Neurol Sci; 2020 Mar; 41(3):537-542. PubMed ID: 31833000
[TBL] [Abstract][Full Text] [Related]
4. Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea.
Schulman EA
Headache; 2012 Feb; 52(2):204-12. PubMed ID: 22229837
[TBL] [Abstract][Full Text] [Related]
5. Diclofenac with or without an antiemetic for acute migraine headaches in adults.
Derry S; Rabbie R; Moore RA
Cochrane Database Syst Rev; 2012 Feb; 2(2):CD008783. PubMed ID: 22336852
[TBL] [Abstract][Full Text] [Related]
6. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
7. Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.
Dodick DW; Tepper SJ; Friedman DI; Gelfand AA; Kellerman DJ; Schmidt PC
Headache; 2018 Jul; 58(7):986-992. PubMed ID: 29782049
[TBL] [Abstract][Full Text] [Related]
8. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
9. Diclofenac with or without an antiemetic for acute migraine headaches in adults.
Derry S; Rabbie R; Moore RA
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD008783. PubMed ID: 23633360
[TBL] [Abstract][Full Text] [Related]
10. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
[TBL] [Abstract][Full Text] [Related]
11. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
[TBL] [Abstract][Full Text] [Related]
12. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
Krymchantowski AV; Barbosa JS
Cephalalgia; 2002 May; 22(4):309-12. PubMed ID: 12100094
[TBL] [Abstract][Full Text] [Related]
13. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
14. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
[TBL] [Abstract][Full Text] [Related]
15. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
16. Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system.
Smith TR; Goldstein J; Singer R; Pugach N; Silberstein S; Pierce MW
Headache; 2012 Apr; 52(4):612-24. PubMed ID: 22352764
[TBL] [Abstract][Full Text] [Related]
17. Acute migraine treatment with oral triptans and NSAIDs in a managed care population.
Ng-Mak DS; Hu XH; Chen YT; Ma L
Headache; 2008 Sep; 48(8):1176-85. PubMed ID: 18819177
[TBL] [Abstract][Full Text] [Related]
18. Intranasal ketorolac tromethamine (SPRIX(R)) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: safety and efficacy data from a phase II clinical trial.
Pfaffenrath V; Fenzl E; Bregman D; Färkkila M
Cephalalgia; 2012 Jul; 32(10):766-77. PubMed ID: 22711895
[TBL] [Abstract][Full Text] [Related]
19. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR
Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
[TBL] [Abstract][Full Text] [Related]
20. Identification of negative predictors of pain-free response to triptans: analysis of the eletriptan database.
Diener HC; Dodick DW; Goadsby PJ; Lipton RB; Almas M; Parsons B
Cephalalgia; 2008 Jan; 28(1):35-40. PubMed ID: 17941878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]